<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T06:08:07Z</responseDate>
  <request identifier="oai:figshare.com:article/34045983" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34045983</identifier>
        <datestamp>2026-10-01T13:19:53Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Analysis of the influence of rs1801265 polymorphism on DPD enzyme activity and contributing factors in the Chinese population</dc:title>
          <dc:creator>Linkun Pan (25156644)</dc:creator>
          <dc:creator>Yang Shen (66591)</dc:creator>
          <dc:creator>Haibo Jiang (574973)</dc:creator>
          <dc:creator>Fangling Wu (8199012)</dc:creator>
          <dc:creator>Nan Wang (21935)</dc:creator>
          <dc:creator>Mengzhen Zhang (12041408)</dc:creator>
          <dc:creator>Kui Yang (83118)</dc:creator>
          <dc:creator>Jiajie Luan (6709523)</dc:creator>
          <dc:creator>Maodi Xu (14012820)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>DPYD</dc:subject>
          <dc:subject>DPD activity</dc:subject>
          <dc:subject>5-fluorouracil</dc:subject>
          <dc:subject>SNP loci</dc:subject>
          <dc:subject>Chinese population</dc:subject>
          <dc:subject>personalized medicine</dc:subject>
          <dc:description>&lt;p&gt;Dihydropyrimidine dehydrogenase (DPD), encoded by DPYD, is essential for 5-fluorouracil (5-FU) metabolism, yet functional variants remain understudied in Chinese populations.&lt;/p&gt; &lt;p&gt;We enrolled 300 healthy Chinese subjects and measured DPD activity as the HPLC-based 5-FU degradation rate in PBMCs. Five DPYD SNPs selected from NCBI and PharmGKB were genotyped by SNaPshot; genotype–degradation-rate associations were assessed by univariate and multivariable regression with FDR correction, and functional consequences predicted using PolyPhen-2, SIFT, SWISS-MODEL and molecular docking.&lt;/p&gt; &lt;p&gt;The median degradation rate was 1.140 ng/mL/10&lt;sup&gt;6&lt;/sup&gt; cells/min. c.85T &gt; C (rs1801265) was the only variant associated with a higher degradation rate (&lt;i&gt;p&lt;/i&gt; = 0.0041) and remained independently associated in the multivariable model; it is common in Asians (MAF ~7%). In 39 colorectal cancer patients receiving 5-FU-based chemotherapy, carriers showed numerically lower 5-FU AUC and shorter progression-free survival, without statistical significance. Molecular modeling predicted that the Cys29Arg substitution alters DPD conformation and 5-FU binding.&lt;/p&gt; &lt;p&gt;&lt;i&gt;DPYD&lt;/i&gt; c.85T &gt; C (rs1801265) was associated with higher 5-FU degradation capacity in Chinese subjects and is predicted to increase DPD activity. If confirmed, this gain-of-function effect may reduce fluoropyrimidine toxicity but could also warrant dose escalation to maintain efficacy; direct functional assays and prospective patient-cohort validation are required before clinical use.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T13:19:53Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.6084/m9.figshare.34045983.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/Analysis_of_the_influence_of_rs1801265_polymorphism_on_DPD_enzyme_activity_and_contributing_factors_in_the_Chinese_population/34045983</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
